Sandhoff Disease without Hepatosplenomegaly Due to Hexosaminidase B Gene Mutation.
Gowda VK +3 more
europepmc +1 more source
Five-year analysis of efficacy and safety of a bidirectional AAV gene therapy in Tay-Sachs sheep. [PDF]
Taghian T +36 more
europepmc +1 more source
Normalization of hepatic homeostasis in the Npc1nmf164 mouse model of Niemann-Pick type C disease treated with the histone deacetylase inhibitor vorinostat [PDF]
al, et, Ory, Daniel S.
core +1 more source
Sinbaglustat is efficacious in GM2 gangliosidosis primarily through inhibition of GBA2 rather than GCS. [PDF]
Steiner MA +8 more
europepmc +1 more source
Microglia-neuron crosstalk through Hex-GM2-MGL2 maintains brain homeostasis. [PDF]
Frosch M +21 more
europepmc +1 more source
Intrathecal delivery of AAVrh10-mHexa combined with anti-inflammatory treatment reduces neuropathological markers and extends the lifespan of mice with early-onset Tay-Sachs disease. [PDF]
Can M, Ausseil J, Seyrantepe V.
europepmc +1 more source
Related searches:
Thalamic hyperdensity — is it a diagnostic marker for Sandhoff disease?
Brain and Development, 1993Sandhoff disease, also known as GM2-gangliosidoses variant 0, is caused by the deficient activity of both hexosaminidase A and hexosaminidase B. We report a 15-month-old boy diagnosed with Sandhoff disease by demonstrating the enzyme deficiency. The interesting finding was bilateral thalamic hyperdensity on the CT scan.
Meral Özmen +2 more
exaly +3 more sources

